Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics Statistics

Total Valuation

EWTX has a market cap or net worth of $1.73 billion. The enterprise value is $1.14 billion.

Market Cap	1.73B
Enterprise Value	1.14B

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

EWTX has 105.35 million shares outstanding. The number of shares has increased by 25.66% in one year.

Current Share Class	105.35M
Shares Outstanding	105.35M
Shares Change (YoY)	+25.66%
Shares Change (QoQ)	+10.31%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	72.04%
Float	60.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.94
P/TBV Ratio	2.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.87, with a Debt / Equity ratio of 0.01.

Current Ratio	28.87
Quick Ratio	28.43
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.41% and return on invested capital (ROIC) is -19.67%.

Return on Equity (ROE)	-27.41%
Return on Assets (ROA)	-19.06%
Return on Invested Capital (ROIC)	-19.67%
Return on Capital Employed (ROCE)	-29.46%
Revenue Per Employee	n/a
Profits Per Employee	-$1.37M
Employee Count	110
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.06% in the last 52 weeks. The beta is 0.29, so EWTX's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-53.06%
50-Day Moving Average	15.01
200-Day Moving Average	17.63
Relative Strength Index (RSI)	59.30
Average Volume (20 Days)	737,831

Short Selling Information

The latest short interest is 8.62 million, so 8.18% of the outstanding shares have been sold short.

Short Interest	8.62M
Short Previous Month	7.31M
Short % of Shares Out	8.18%
Short % of Float	14.23%
Short Ratio (days to cover)	8.87

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-174.54M
Pretax Income	-150.70M
Net Income	-150.70M
EBITDA	-172.39M
EBIT	-174.54M
Earnings Per Share (EPS)	-$1.55

Balance Sheet

The company has $593.99 million in cash and $4.37 million in debt, giving a net cash position of $589.62 million or $5.60 per share.

Cash & Cash Equivalents	593.99M
Total Debt	4.37M
Net Cash	589.62M
Net Cash Per Share	$5.60
Equity (Book Value)	589.07M
Book Value Per Share	5.59
Working Capital	582.36M

Cash Flow

In the last 12 months, operating cash flow was -$124.78 million and capital expenditures -$888,000, giving a free cash flow of -$125.67 million.

Operating Cash Flow	-124.78M
Capital Expenditures	-888,000
Free Cash Flow	-125.67M
FCF Per Share	-$1.19

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EWTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.66%
Shareholder Yield	n/a
Earnings Yield	-8.71%
FCF Yield	-7.26%

Analyst Forecast

The average price target for EWTX is $37.90, which is 130.82% higher than the current price. The consensus rating is "Buy".

Price Target	$37.90
Price Target Difference	130.82%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1